Observational Study of VYKAT™ XR in Patients With Prader-Willi Syndrome
NCT07450664
·
clinicaltrials.gov ↗
ENROLLING_BY_INVITATION
Status
200
Enrollment
INDUSTRY
Sponsor class
Conditions
Prader-Willi Syndrome
Interventions
DRUG:
VYKAT XR
Sponsor
Soleno Therapeutics, Inc.